PRESS RELEASE published on 12/05/2025 at 18:34, 11 days 22 hours ago VALNEVA Déclaration d’actions et de droits de vote : 30 novembre 2025 VALNEVA déclare des actions et des droits de vote, dont un passage en droit de vote double et un exercice d'options de souscription d'actions. Informations sur le siège social et le marché réglementé Euronext Paris Déclaration Droits De Vote Actions Valneva
PRESS RELEASE published on 12/05/2025 at 18:34, 11 days 22 hours ago VALNEVA Declaration of shares and voting rights: November 30, 2025 VALNEVA declares changes in shares and voting rights, including double voting rights granted on ordinary shares and transfer into bearer form Euronext Paris Voting Rights Shares Valneva Double Voting Rights
BRIEF published on 12/03/2025 at 11:03, 14 days 6 hours ago Valneva SE : Développements prometteurs dans le domaine du vaccin contre la maladie de Lyme Valneva SE Vaccin Contre La Maladie De Lyme Prévisions Du Marché Pfizer VLA15
BRIEF published on 12/03/2025 at 11:03, 14 days 6 hours ago Valneva SE: Promising Developments in Lyme Disease Vaccine Valneva SE Lyme Disease Vaccine Market Forecast Pfizer VLA15
PRESS RELEASE published on 12/03/2025 at 10:58, 14 days 6 hours ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Buy recommendation for Valneva SE, raising target price to €6.80. VLA15 vaccine progress and market potential analyzed Buy Recommendation Research Update Valneva SE Market Potential VLA15 Vaccine
BRIEF published on 11/04/2025 at 07:05, 1 month 13 days ago Valneva's Phase 1 Trial Yields Positive Results for Zika Vaccine Phase 1 Trial Valneva Immunogenicity Zika Vaccine Adjuvant
BRIEF published on 11/04/2025 at 07:05, 1 month 13 days ago L'essai de phase 1 de Valneva donne des résultats positifs pour le vaccin contre le Zika Valneva Immunogénicité Essai De Phase 1 Adjuvant Vaccin Contre Le Zika
PRESS RELEASE published on 11/04/2025 at 07:00, 1 month 13 days ago Valneva annonce des résultats positifs de Phase 1 pour son candidat vaccin de deuxième génération contre le virus Zika Valneva annonce des résultats positifs de phase 1 pour son candidat vaccin de deuxième génération contre le virus Zika, montrant une réponse immunitaire améliorée Valneva Immunitaire Phase 1 Vaccin Zika
PRESS RELEASE published on 11/04/2025 at 07:00, 1 month 13 days ago Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate Valneva SE reports positive Phase 1 trial results for VLA1601, its second-generation Zika vaccine candidate, showing improved immune response. Safety and immunogenicity demonstrated in trial Phase 1 Trial Valneva SE Safety Immunogenicity Zika Vaccine
BRIEF published on 10/09/2025 at 16:04, 2 months 8 days ago Franchissement de Seuil par Bpifrance dans le Capital de Valneva SE Franchissement De Seuil Valneva SE Bpifrance Caisse Des Dépôts Marché Actions
Published on 12/17/2025 at 15:00, 2 hours 6 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 3 hours 6 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/17/2025 at 13:35, 3 hours 31 minutes ago Silver X Mining Announces Grant of Incentive Stock Options and Restricted Share Units
Published on 12/17/2025 at 13:15, 3 hours 51 minutes ago Aclara Wins UN Global Compact Award for Its Contribution to Local Employment and Suppliers
Published on 12/17/2025 at 13:00, 4 hours 6 minutes ago Gold Terra Provides a Summary of 2025 Achievements and 2026 Plan
Published on 12/17/2025 at 16:05, 1 hour 1 minute ago TCL to Display the Future with Advanced Visual Innovations and AI-Powered Product Portfolio at CES 2026
Published on 12/17/2025 at 16:03, 1 hour 3 minutes ago 1&1 mobile network reaches 25 percent of German households
Published on 12/17/2025 at 15:32, 1 hour 34 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Published on 12/16/2025 at 21:45, 19 hours 21 minutes ago Mise à disposition du rapport financier annuel
Published on 12/16/2025 at 20:10, 20 hours 56 minutes ago donation of shares of Seval, member of the Feuillet family concert
Published on 12/16/2025 at 20:10, 20 hours 56 minutes ago Donation de titres de la société Seval, membre du concert familial Feuillet
Published on 12/16/2025 at 18:53, 22 hours 13 minutes ago Number of shares and voting rights - November 2025 (In French only)
Published on 12/16/2025 at 18:53, 22 hours 13 minutes ago Nombre total d'actions et droits de vote - novembre 2025
